Haemophilia, aging and sexuality

Haemophilia

Volumn 15, Issue 1, 2009, Pages 55-62

  Gianotten, Woet L ^a   Heijnen, L ^b  

^a Rehabilitation Centre De Trappenberg   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Aging; Arthropathy; Erectile dysfunction; Haemophilia; Posoasbleed; Sexuality

Indexed keywords

ANALGESIC AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIVIRUS AGENT; ATENOLOL; PEGINTERFERON ALPHA2B; PHOSPHODIESTERASE V INHIBITOR; RIBAVIRIN; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; TADALAFIL; TESTOSTERONE; TRICYCLIC ANTIDEPRESSANT AGENT; VARDENAFIL;

AGING; ARTERIOSCLEROSIS; ARTHROPATHY; DEPRESSION; DIABETES MELLITUS; DIZZINESS; DYSPEPSIA; EPISTAXIS; FATIGUE; FLUSHING; HEADACHE; HEALTH CARE PERSONNEL; HEMOPHILIA; HEPATITIS C; HUMAN; HYPERTENSION; ILIOPSOAS MUSCLE; MEDICAL INFORMATION; MUSCLE BLEEDING; MUSCULOSKELETAL DISEASE; NOSE CONGESTION; PAIN; PATIENT REFERRAL; PENIS ERECTION; PHYSICAL ACTIVITY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RHINITIS; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUALITY; SIDE EFFECT;

AGED; AGING; DEPRESSION; ERECTILE DYSFUNCTION; HEMOPHILIA A; HEMORRHAGE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; MALE; MUSCULAR DISEASES; SEXUALITY;

EID: 63049125914     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01914.x     Document Type: Review

References (53)

1. Nilsson IM, Berntorp E, Lofqvist T, Pettersson H. Twenty-five years experience of prophylactic replacement therapy in severe haemophilia A and B. J Intern Med 1992; 232: 25-32.
2. Ahlberg A. Haemophilia in Sweden; Incidence, treatment and prophylaxis of arthropathy and other musculoskeletal manifestations of haemophilia A and B. Acta Orthop Scand 1965; 35(Suppl. 77): 3-132.
3. Plug I, van der Bom JG, Peters M et al. Mortality and causes of death in patients with hemophilia, 1992-2001: A prospective cohort study. J Tromb Haemost 2006; 4: 510-6.
4. Mauser-Bunschoten EP, De Knecht-van Eekelen A, Smit C. Aging with Hemophilia. Medical and Psychosocial Impact. Utrecht: Van Creveldkliniek-Haematology, 2007.
5. Sipski ML, Alexander CJ. Basic sexual function over time. In: Sipski ML, Alexander CJ eds. Sexual Function in People with Disability and Chronic illness. Gaithersburg: Aspen, 1997: 75-83.
6. Schover LR, Jensen SB. Sexuality and Chronic Illness - A Comprehensive Approach. New York: The Guilford Press, 1988.
7. Parish KL. Sexuality and haemophilia: Connections across the life-span. Haemophilia 2002; 8: 353.
8. Plug I, van der Bom JG, Peters M et al. Thirty years of hemophilia treatment in the Netherlands, 1972-2001. Blood 2004; 104: 3494-500.
9. Mauser-Bunschoten EP, van Drimmelen AA, van den Berg HM, et al. HIV infection in Dutch Hemophilia patients; a 15years follow up study. In: Mauser-Bunschoten EP, ed. Complications of Hemophilia Care. HIV-Infection in Dutch Hemophilia Patients. Academic Thesis: University of Utrecht, Utrecht, 1995: 53-63.
10. Ragin MV, Tegtmeijer GE, Levy JA et al. AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: Prevalence, seroconversion rate, and clinical correlations. Blood 1986; 67: 592-5.
11. http://www.unaids.org/en/HIV_data/epi2006/default.asp.
12. Mauser-Bunschoten EP, Bresters D, van Drimmelen AA et al. Hepatitis C infection and viremia in Dutch hemophilia patients. J Med Virol 1995; 45: 241-6.
13. Fried MW, Shiffman ML, Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2004; 347: 975-82.
14. Posthouwer D, Plug I, van der Bom JG, Rosendaal FR, Mauser-Bunschoten EP. Hepatitis C and health related quality of life among patients with haemophilia. Haematologica 2005; 90: 846-50.
15. Slavenburg S, Verduyn-Lunel FM, Hermsen JT, Melchers WJ, te Morsche RH, Drenth JP. Prevalence of hepatitis C in the general population in the Netherlands. Neth J Med 2008; 66: 13-7.
16. Hill J, Bird H, Thorpe R. Effects of rheumatoid arthritis on sexual activity and relationships. Rheumatology (Oxford) 2003; 42: 280-6.
17. Berlo van WTM, Wiel van de HBM, Taal E et al. Sexual functioning of people with RA compared with healthy controls. Clin Rheum 2007; 26: 30-8.
18. Fernandez-Palazzi F, Hernandez SR, De Bosch NB, De Saez AR. Hematomas within the iliopsoas muscles in hemophilic patients: The Latin American experience. Clin Orthop Relat Res 1996; 328: 19-24.
19. Ashrani AA, Osip J, Christie B, Key NS. Iliopsoas haemorrhage in patients with bleeding disorders experience from one centre. Haemophilia 2003; 9: 721-6.
20. Balkan C, Kavakli K, Karapinar D. Iliopsoas haemorrhage in patients with haemophilia: Results from one centre. Haemophilia 2005; 11: 463-7.
21. Kulkarni R, Soucie JM, Evatt B, Haemophilia Surveillance System Project Investigators. Renal disease among males with Haemophilia. Haemophilia 2003; 9: 703-10.
22. Crenshaw TL, Goldberg JP. Sexual side-effect research. In: Crenshaw TL, Goldberg JP, eds. Sexual Pharmacology. New York: Norton & Cy, 1996: 197-207.
23. Kulkarni R, Soucie JM, Evatt BL, Haemophilia Surveillance System Project Investigators. Prevalence and risk factors for heart disease among males with Haemophilia. Am J Hematol 2005; 79: 36-42.
24. Bresters D, Mauser-Bunschoten EP, Reesink HW et al. Sexual transmission of hepatitis C. Lancet 1993; 342: 210-1.
25. Osmond DH, Padian NS, Sheppard HW et al. Risk factors for hepatitis C virus seropositivity in heterosexual couples. JAMA 1993; 269: 361-5.
26. Danoff A, Khan O, Wan DW et al. Sexual dysfunction is highly prevalent among men with chronic hepatitis C virus infection and negatively impacts health-related quality of life. Am J Gastroenterol 2006; 101: 1235-43.
27. Soykan A, Boztas H, Idilman R et al. Sexual dysfunctions in HCV patients and its correlations with psychological and biological variables. Int J Impot Res 2005; 17: 175-9.
28. Kraus MR, Schafer A, Csef H, Scheurlen M. Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C. World J Gastroenterol 2005; 11: 1769-74.
29. Kraus MR, Schafer A, Bentink T et al. Sexual dysfunction in males with chronic hepatitis C and antiviral therapy: Interferon-induced functional androgen deficiency or depression? J Endocrinol 2005; 185: 345-52.
30. Ende AR, Lo Re V III, DiNubile MJ, Mounzer K. Erectile dysfunction in an urban HIV-positive population. AIDS Patient Care STDS 2006; 20: 75-8.
31. Lamba H, Goldmeier D, Mackie NE, Scullard G. Antiretroviral therapy is associated with sexual dysfunction and with increased serum oestradiol levels in men. Int J STD AIDS 2004; 15: 234.
32. Colson AE, Keller MJ, Sax PE, Pettus PT, Platt R, Choo PW. Male sexual dysfunction associated with antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 30: 27-32.
33. Dieperink E, Ho SB, Thuras P, Willenbring ML. A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics 2003; 44: 104-12.
34. Asnis GM, De La Garza R II. Interferon-induced depression in chronic hepatitis C: A review of its prevalence, risk factors, biology, and treatment approaches. J Clin Gastroenterol 2006; 40: 322-35.
35. Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol 1998; 13: S1-4.
36. Bancroft J, Janssen E, Strong D et al. The relation between mood and sexuality in heterosexual men. Arch Sex Behav 2003; 32: 217-30.
37. Kennedy SH, Dickens SE, Eisfeld BS et al. Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord 1999; 56: 201-8.
38. Montejo AL, Llorca G, Izquierdo JA et al. Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients. J Clin Psychiatry 2001; 62(Suppl. 3): 10-21.
39. Lewis RW, Fugl-Meyer KS, Bosch R, et al. Epidemiology/risk factors of sexual dysfunction. J Sex Med 2004; 1: 35-9.
40. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States; prevalence and predictors. JAMA 1999; 281: 537-44.
41. Street A, Hill K, Sussex B, Warner M, Scully MF. Haemophilia and ageing. Haemophilia 2006; 12: 8-12.
42. Whipple B, Knowles J, Davis J. The health benefits of sexual expression. In: Tepper MS, Owens AF, eds. Sexual Health, Vol. 1. Psychological Foundations. Westport: Praeger; 2007:17-28.
43. Gianotten WL, Whipple B, Owens AF. Sexual activity is a cornerstone of quality of life. An update of 'The health benefits of sexual expression'. In: Tepper MS, Owens AF eds. Sexual Health, Vol 1, Psychological Foundations. Westport: Praeger, 2007: 28-42.
44. Annon JS. The Behavioural Treatment of Sexual Problems. Vol. 1. Brief Therapy. Honolulu: Kapiolani Health Services, 1974.
45. Hicklin LA, Ryan C, Wong DK, Hinton AE. Nose-bleeds after sildenafil (Viagra). J R Soc Med 2002; 95: 402-3.
46. Ismail H, Harries PG. Recurrent epistaxis after treatment with tadalafil (Cialis). Acta Otolaryngol 2005; 125: 334-5.
47. Berkels R, Klotz T, Sticht G, Englemann U, Klaus W. Modulation of human platelet aggregation by the phosphodiesterase type 5 inhibitor sildenafil. J Cardiovasc Pharmacol 2001; 37: 413-21.
48. Murphy MR, Seckl JR, Burton S, Checkley SA, Lightman SL. Changes in oxytocin and vasopressin secretion during sexual activity in men. J Clin Endocrinol Metab 1987; 65: 738.
49. Biering-Sørensen F, Laeessøe L, Sønksen J, Bagi P, Nielsen JB, Kristensen JK. The effect of penile vibratory stimulation on male fertility potential, spasticity and neurogenic detrusor overactivity in spinal cord lesioned individuals. Acta Neurochir Suppl 2005; 93: 159-63.
50. Alaca R, Goktepe AS, Yildiz N, Yilmaz B, Gunduz S. Effect of penile vibratory stimulation on spasticity in men with spinal cord injury. Am J Phys Med Rehabil 2005; 84: 875-9.
51. Leitzmann MF, Platz EA, Stampfer MJ, Willett WC, Giovannucci E. Ejaculation frequency and subsequent risk of prostate cancer. JAMA 2004; 291: 1578-86.
52. Giles GG, Severi G, English DR et al. Sexual factors and prostate cancer. BJU Int 2003; 92: 211-6.
53. Davey Smith G, Frankel S, Yarnell J. Sex and death: Are they related? Findings from the Caerphilly Cohort Study. BMJ 1997; 315: 1641-4.